06.10.2017 13:28:51

Constellation Brands A Outperform

Der Analyst RBC Capital Markets hat das Kursziel für Constellation Brands Inc (A) von 222 auf 226 USD angehoben, aber die Einstufung auf "Outperform" belassen.
Zusammenfassung: Constellation Brands Inc (A) Outperform
Unternehmen:
Constellation Brands Inc (A)
Analyst:
RBC Capital Markets
Kursziel:
$ 226,00
Rating jetzt:
Outperform
Kurs*:
$ 209,25
Abst. Kursziel*:
8,00%
Rating update:
reiterated
Kurs aktuell:
$ 224,44
Abst. Kursziel aktuell:
0,70%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Nachrichten zu Constellation Brands Inc (A)

  • Relevant
  • Alle
  • vom Unternehmen

Aktienempfehlungen zu Constellation Brands Inc (A)

  • Alle
  • Buy
  • Hold
  • Sell
14.12.17 Constellation Brand a Buy Deutsche Bank AG
06.10.17 Constellation Brand a Outperform RBC Capital Markets
06.10.17 Constellation Brand a Buy Stifel, Nicolaus & Co., Inc.
30.06.17 Constellation Brand a Buy Stifel, Nicolaus & Co., Inc.
29.06.17 Constellation Brand a Buy Pivotal Research Group
mehr Aktienempfehlungen

Aktien in diesem Artikel

Constellation Brands Inc (A) 189,58 2,48% Constellation Brands Inc (A)

Aktienempfehlungen

15.12.17 Oracle Sector Perform RBC Capital Markets
15.12.17 S&P Global overweight Barclays Capital
15.12.17 Sanderson Farms Equal weight Barclays Capital
15.12.17 Taubman Centers Market Perform BMO Capital Markets
15.12.17 Penumbra Market Perform BMO Capital Markets
15.12.17 Abbott Laboratories Outperform BMO Capital Markets
15.12.17 Progressive Waste Solutions Outperform BMO Capital Markets
15.12.17 Magellan Midstream Partners LP Outperform BMO Capital Markets
15.12.17 scPharmaceuticals Outperform BMO Capital Markets
15.12.17 Sonoco Products Equal weight Barclays Capital
15.12.17 Sealed Air overweight Barclays Capital
15.12.17 Hi-Crush Partners LP Partnership Interest Equal weight Barclays Capital
15.12.17 Windstream Underweight Barclays Capital
15.12.17 Frontier Communications Underweight Barclays Capital
15.12.17 CenturyLink Equal weight Barclays Capital
15.12.17 Intra-Cellular Therapies Buy Canaccord Adams
15.12.17 Biohaven Pharmaceutical Buy Canaccord Adams
15.12.17 Siemens buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
15.12.17 Adobe Hold Pivotal Research Group
15.12.17 Oracle Conviction Buy List Goldman Sachs Group Inc.
15.12.17 O Reilly Automotive Neutral Wedbush Morgan Securities Inc.
15.12.17 Sovran Self Storage Sell UBS AG
15.12.17 Entegris Buy Seaport Global Securities
15.12.17 Foot Locker Buy Canaccord Adams
15.12.17 Wayfai a Buy Stifel, Nicolaus & Co., Inc.
15.12.17 Under Armour Buy Stifel, Nicolaus & Co., Inc.
15.12.17 Fitbit Sell Stifel, Nicolaus & Co., Inc.
15.12.17 CROCS Buy Stifel, Nicolaus & Co., Inc.
15.12.17 Juniper Networks Hold Stifel, Nicolaus & Co., Inc.
15.12.17 Cisco Hold Stifel, Nicolaus & Co., Inc.
15.12.17 Arista Networks Buy Stifel, Nicolaus & Co., Inc.
15.12.17 Nordson Hold Gabelli & Co
15.12.17 21st Century Fox (A) Market Perform Telsey Advisory Group
15.12.17 Nike buy Stifel, Nicolaus & Co., Inc.
15.12.17 Coca-Cola Neutral JP Morgan Chase & Co.
15.12.17 Stabilus Hold Kepler Cheuvreux
15.12.17 Aurubis (ex Norddeutsche Affinerie) buy Kepler Cheuvreux
15.12.17 Continental buy Kepler Cheuvreux
15.12.17 FormFactor Strong Buy Needham & Company, LLC
15.12.17 Aurubis (ex Norddeutsche Affinerie) kaufen Norddeutsche Landesbank (Nord/LB)
15.12.17 Deutsche Bank Halten Norddeutsche Landesbank (Nord/LB)
15.12.17 Johnson Outdoors Outperform Imperial Capital
15.12.17 Solaris Oilfield Infrastructur a Outperform Imperial Capital
15.12.17 Adobe Outperform BMO Capital Markets
15.12.17 Oracle Outperform BMO Capital Markets
15.12.17 Valeant Pharmaceuticals International Underperform Mizuho
15.12.17 Costco Wholesale Outperform Telsey Advisory Group
15.12.17 Delta Air Lines Outperform Cowen and Company, LLC
15.12.17 Cardiovascular Systems Hold Needham & Company, LLC
15.12.17 Express Scripts Outperform Robert W. Baird & Co. Incorporated